Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 16p12 1p12 3 Triplication Syndrome C5680097
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 16p12 1p12 3 Triplication Syndrome for differential diagnosis and treatment planning.
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
A rare genetic disorder affecting adrenal hormone production. It can cause ambiguous genitalia, salt-wasting crises, and hormonal imbalances. Treatment requires hormone replacement therapy and careful monitoring.
16p12 1p12 3 Triplication Syndrome C5680097
An extremely rare chromosomal disorder involving three copies of genetic material on chromosome 16. Limited cases are reported, and features may include developmental delays and physical differences. Care is individualized based on specific needs.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
16p12 1p12 3 Triplication Syndrome C5680097
0-null
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
16p12 1p12 3 Triplication Syndrome C5680097
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
16p12 1p12 3 Triplication Syndrome C5680097
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
16p12 1p12 3 Triplication Syndrome C5680097
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
16p12 1p12 3 Triplication Syndrome C5680097
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
16p12 1p12 3 Triplication Syndrome C5680097
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 16p12-1p12-3-triplication-syndrome-C5680097 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 16p12 1p12 3 Triplication Syndrome C5680097 | Discriminating power |
|---|---|---|---|
| Salt-wasting crisis | May occur from impaired adrenal steroid production, especially in infancy. | Not an established feature of the chromosomal triplication. | High |
| Genital development | Ambiguous genitalia may occur from disordered sex-steroid synthesis. | Physical differences may occur, but genital ambiguity is not established. | Moderate |
| Development | Developmental effects are not the defining feature in the supplied description. | Developmental delay is a reported possible feature in limited cases. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with suspected adrenal crisis
Salt-wasting and hormone imbalance fit the endocrine disorder better.
High
Abnormal steroid profile
Disordered adrenal steroidogenesis supports enzyme deficiency rather than triplication.
Moderate
Ambiguous genitalia with electrolyte concern
Combined genital and adrenal findings favor the left condition.
Moderate
Choose 16p12 1p12 3 Triplication Syndrome C5680097 when
Chromosomal microarray abnormality
A confirmed 16p12.1p12.3 triplication directly supports the right diagnosis.
High
Developmental delay without adrenal crisis
Neurodevelopmental features fit the sparse chromosomal description better.
Low
Multiple congenital differences
A congenital chromosomal pattern is more consistent than isolated steroidogenic disease.
Low
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 16p12 1p12 3 Triplication Syndrome C5680097 | Interpretation |
|---|---|---|---|
| Serum electrolytes | May show salt-wasting abnormalities; exact cutoffs are not supplied. | No characteristic electrolyte pattern is established. | Abnormal results suggest adrenal imbalance but are not diagnostic alone. |
| Steroid hormone profile | May show disordered adrenal steroid production. | No specific steroid pattern is established. | Pattern interpretation requires specialist endocrine review. |
| Chromosomal microarray | Not expected to show 16p12.1p12.3 triplication. | May identify three copies of the relevant chromosome 16 region. | Genetic confirmation distinguishes the chromosomal condition. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Chronic severe endocrine disorder; outcome depends on recognition and hormone replacement, but mortality is not quantified here.
- Factors
- Salt-wasting risk, hormone balance, and monitoring adherence.
16p12 1p12 3 Triplication Syndrome C5680097
- Outcome
- Chronic congenital condition with uncertain prognosis because reported cases are extremely limited.
- Factors
- Developmental needs, associated physical findings, and available supports.
Time frame: Lifelong for both; early course may differ and is not fully established.
Confirmed diagnosis, complications, specialist follow-up, and individualized support.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal crisis | A recognized potential emergency from hormone deficiency. Not established from the supplied description. Urgent clinician assessment is needed for suspected crisis. |
| Developmental disability | Not established as a core complication here. Developmental delay may occur, with severity uncertain. Support needs should be individualized. |
| Physical differences | Genital ambiguity may be present. Physical differences may occur, but the spectrum is poorly defined. Findings should not be generalized beyond reported cases. |
Patient education highlights
- HighEmergency signs
Seek urgent care for vomiting, lethargy, dehydration, or suspected salt-wasting in the endocrine disorder.
- MediumTesting limits
An abnormal laboratory result is not itself a diagnosis and needs specialist interpretation.
- MediumIndividualized care
Both conditions are rare; monitoring and support depend on confirmed findings and individual needs.